GenMark Diagnostics, Inc. (GNMK) has 522 open-market insider trades by 27 insiders since 2010. The most active filer is Michael Gleeson, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Christopher M. Gleeson | Dir | — | 3 | $8.3M | 2014-05-29 |
| Scott Mendel | CEOPres | — | 54 | $5.8M | 2021-04-22 |
| Hany Massarany | CEOPres | — | 47 | $4.4M | 2020-01-23 |
| Michael Gleeson | VP | — | 71 | $4.2M | 2021-04-22 |
| Jennifer Anne Williams | VP | — | 50 | $3.2M | 2018-08-24 |
| Eric Stier | CLOVP | — | 66 | $2.9M | 2021-04-22 |
| Jon Faiz Kayyem | VP | — | 35 | $2.5M | 2018-02-02 |
| Alan Baer Maderazo | VP | — | 10 | $2.2M | 2021-04-22 |
| John Frederick Ek | CFO | — | 23 | $1.7M | 2021-04-22 |
| Tyler Jensen | VP | — | 23 | $1.5M | 2021-04-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Tyler Jensen | SVP & Engineering and Tech Dev | Sell | $12K | 2021-03-18 |
| Christine Shaw | VP & Assay Development | Sell | $5K | 2021-03-05 |
| Tyler Jensen | SVP & Engineering and Tech Dev | Sell | $9K | 2021-03-04 |
| Alan Baer Maderazo | VP & Qual +2 | Sell | $41K | 2021-03-01 |
| Christine Shaw | VP | Sell | $107K | 2021-02-26 |
| Michael John Harkins | VP | Sell | $422K |
Companies that share insiders with GNMK, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-02-26 |
| Michael Gleeson | VP | Sell | $604K | 2021-02-26 |
| Sarah Hollis Winkler | VP | Sell | $380K | 2021-02-26 |
| Alan Baer Maderazo | VP & Qual +2 | Sell | $5K | 2021-02-25 |
| Alan Baer Maderazo | VP & Qual +2 | Sell | $3K | 2021-02-24 |
| Michael Gleeson | SVP & Corp. Accounts | Sell | $75K | 2021-02-23 |
| Christine Shaw | VP & Assay Development | Sell | $8K | 2021-02-23 |
| Alan Baer Maderazo | VP & Qual +2 | Sell | $6K | 2021-02-22 |
| Michael Gleeson | VP | Sell | $51K | 2021-02-19 |
| Sarah Hollis Winkler | VP & Human Resources | Sell | $14K | 2021-02-19 |